The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
500 jobs Number of planned job creations
Announcement Date
12 September 2006
Employment effect (start)
Foreseen end date
31 December 2007
Description
US healthcare group Abbott has unveiled a new 90 million euro manufacturing facility in Clonmel, Tipperary, in a move to expand its vascular operations. Abbott is planning to increase employment by 500 by the end of 2007. The Clonmel plant will eventually employ 1350. Total Abbott employment in Ireland is currently 3300. The plant will manufacture drug-eluting stents, which are used to treat heart problems.
Sources
20 September 2013: The Irish Times
20 September 2013: The Irish Independent
Citation
Eurofound (2006), Abbott, Business expansion in Ireland, factsheet number 64064, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/64064.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
